
Company Info
Phone(516) 767-1800
Year Established
1923
Ticker
OMX: ALK B
Exchange
NASDAQ
Contacts
Jorge AlderetePresident, ALK Americas
Carsten Hellmann
President & CEO
S�ren Niegel
Executive VP, Commercial Operations
Henriette Mersebach
Executive VP, R&D
Claus Steensen S�lje
CFO
Peter Halling
President & CEO (2024)
Company Description
ALK-Abell is a leading producer of pharmaceuticals for specific allergy vaccination to improve the health and quality of life for people with allergies around the world by providing allergy specialists with an extensive supply, professional service, unique products and innovative technology.